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a b s t r a c t
European brown hare syndrome virus (EBHSV) is the aetiological agent of European brown hare
syndrome (EBHS), a disease affecting Lepus europaeus and Lepus timidus ﬁrst diagnosed in Sweden in
1980. To characterize EBHSV evolution we studied hare samples collected in Sweden between 1982 and
2008. Our molecular clock dating is compatible with EBHSV emergence in the 1970s. Phylogenetic
analysis revealed two lineages: Group A persisted until 1989 when it apparently suffered extinction;
Group B emerged in the mid-1980s and contains the most recent strains. Antigenic differences exist
between groups, with loss of reactivity of some MAbs over time, which are associated with amino acid
substitutions in recognized epitopes. A role for immune selection is also supported by the presence of
positively selected codons in exposed regions of the capsid. Hence, EBHSV evolution is characterized by
replacement of Group A by Group B viruses, suggesting that the latter possess a selective advantage.
& 2014 Elsevier Inc. All rights reserved.
Introduction
European brown hare syndrome (EBHS) is a contagious disease
characterized by severe necrotizing hepatitis in European hares
(Lepus europaeus) and, to a lesser extent, in mountain hares (Lepus
timidus) (Gavier-Widén and Mörner, 1991). In the acute form hares
die within a few hours after the appearance of clinical signs
(Gavier-Widén and Mörner, 1991). Although infected, young hares
do not develop EBHS, possibly due to natural resistance (Capucci et
al., 1991; Gavier-Widén and Mörner, 1993; Zanni et al., 1993). The
aetiological agent of EBHS is the European brown hare syndrome
virus (EBHSV), a non-enveloped, single-stranded, positive-sense
RNA virus. EBHSV belongs to the genus Lagovirus, family Calicivir-
idae (King et al., 2012). The other member of this genus, rabbit
haemorrhagic disease virus (RHDV), is responsible for rabbit
haemorrhagic disease (RHD), an acute lethal hepatitis ﬁrst
described in China in 1984 that affects wild and domestic adult
European rabbits (Oryctolagus cuniculus) (Liu et al., 1984). RHD and
EBHS share similar clinical signs and histopathology, as well as a
similar epidemiology (reviewed in Abrantes et al. (2012)). Despite
the close phylogenetic relationship between EBHSV and RHDV,
their antigenic proﬁles are distinct (Capucci et al., 1991; Le Gall et
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al., 1996; Wirblich et al., 1994). They also differ in their evolu-
tionary patterns with a strongest geographical structure for EBHSV
(Le Gall-Reculé et al., 2006).
EBHS was ﬁrst reported in Sweden in 1980 (Gavier-Widén and
Mörner, 1991) and in the following years in several other European
countries (Billinis et al., 2005; Chasey and Duff, 1990; Frölich et al.,
2007; Frölich et al., 1996; Lavazza and Vecchi, 1989; Le Gall et al.,
1996). Indeed, phylogenetic studies suggested that virus disper-
sion occurred from Sweden to west, east and southern Europe
(Frölich et al., 2007). However, EBHSV likely emerged in the early
1970s, as suggested by descriptions of hares with lesions consis-
tent with the disease in 1976 in England (Duff et al., 1994).
Antibodies against the virus have also been found in archived sera
(Duff et al., 1997), and the virus was detected by PCR in samples
collected in Sweden before 1980 (Bascuñana et al., 1997), further
supporting an earlier emergence.
To understand the phylodynamics of EBHSV since its initial
description in 1980 in Sweden, we analysed hare samples col-
lected between 1982 and 2008 in several Swedish geographic
regions, as they reﬂect the spread of the virus in a naïve environ-
ment, along with samples from countries where the disease was
later identiﬁed. In addition, the antigenic proﬁles of EBHSV strains
were assessed with a panel of monoclonal antibodies (MAbs) and
their association with patterns of virus evolution was determined.
Material and methods
Virus samples, RNA extraction and cDNA synthesis
Liver samples from 95 Lepus europaeus and 9 Lepus timidus
found dead in the ﬁeld were collected in different regions of
Sweden between 1982 and 2008 (Fig. 1), resulting from passive
surveillance. Each frozen liver was thawed and either 100 mL of the
obtained exudates or up to 30 mg of the liver were collected.
When using liver pieces, the tissue was homogenized in a rotor-
stator homogenizer (Mixer Mill MM400 from Retsch) at 30 Hz for
7 min. Total RNA was extracted using the RNeasy Mini Kit (Qiagen)
according to the manufacturer's instructions. Reverse transcription
was performed using oligo(dT) as primers (Invitrogen) and Super-
ScriptTM III Reverse Transcriptase (Invitrogen) according to man-
ufacturer's instructions. Sixteen Lepus europaeus liver samples
collected throughout France between 2001 and 2008 by the SAGIR
network (French Wildlife Health Surveillance Network) (Lamarque
et al., 2000) were also analysed. The presence of EBHSV in these
samples was conﬁrmed by ELISA in a laboratory of veterinary
analyses (Anjou Laboratoire, Angers, France). The ﬁve samples
collected before 2003 were previously partially sequenced and
genotyped (Le Gall-Reculé et al., 2006). For the other samples, RNA
extraction and cDNA synthesis were performed as described above
except that SuperScriptTM II Reverse Transcriptase (Invitrogen)
was used for the reverse transcription.
Ampliﬁcation and sequencing
The complete sequence of the gene encoding the capsid protein
was ampliﬁed using the primers EBHSV_VP60_0001FþEBHSV_
VP60_0885R and EBHSV_VP60_0813FþEBHSV_VP60_1728R for the
Swedish samples and EBHSV-29FþEBHSV-1795R for the French
samples (Table 1). After puriﬁcation, PCR products were sequenced
on an automatic sequencer ABI PRISM 310 Genetic Analyzer (PE
Applied Biosystems). The Swedish and French sequences were
determined using the PCR primers as well as several primers
designed in the inner region of the DNA template (primer
sequences available upon request). These sequences have been
deposited in GenBank and assigned the following accession
numbers: KJ679513-KJ679566; AJ971301; AJ971304-6; AJ971311;
AJ971315; FN689419-21; AM408588; AM887765; AM933648-50;
HF571039-40.
Samples fully sequenced for the VP60 gene were aligned using
BioEdit version 7.0.9.0 (Hall, 1999). Four reference EBHSV public
sequences that were collected in 1989 and 1992 in France, Italy
and Germany (GenBank accession numbers Z69620, X98002,
KJ923230 and U09199, respectively) were also included in the
study. In total, 74 complete VP60 sequences were available for
evolutionary analysis.
Analysis of recombination events
Prior to phylogenetic analysis, the sequence alignment was
screened for recombination using the RDP, Geneconv and Bootscan
methods implemented in the Recombination Detection Program
(RDP) version 3.44 (Martin et al., 2010) with the following
parameters: sequences were set to linear, Bonferroni correction,
highest acceptable p-value¼0.05, 100 permutations. Only recom-
bination events detected by all three methods (po0.05) were
considered as signiﬁcant.
Phylogenetic and phylogeographic analysis
The phylogenetic relationships among the capsid sequences
were ﬁrst estimated using the maximum likelihood (ML) method
available within the PhyML package (Guindon et al., 2010). This
analysis utilized the GTRþΓ model of nucleotide substitution and
a combination of SPR and NNI branch-swapping, along with a
bootstrap resampling analysis (1000 replications).
A second phylogenetic analysis was then performed using the
Bayesian Markov chain Monte Carlo (MCMC) method available in
the BEAST package (version 1.7.5; Drummond et al., 2012), which
also allowed us to estimate the rate of nucleotide substitution and
time to the Most Recent Common Ancestor (tMRCA) of our EBHSV
sequences. The GTRþΓþ I (i.e. general time reversible substitution
matrix; Γ, distribution of among-site rate variation, and I, propor-
tion of invariant sites) substitution model and a variety of
coalescent (constant population size, Bayesian skyline, Bayesian
skyride) models were used with relatively uninformative priors, all
of which produced highly comparable results (see Results). To
allow for rate variation among lineages, an uncorrelated lognormal
relaxed molecular clock was used in all cases. Posterior probabil-
ities were determined after 100 million generations, after which
parameters had converged. Statistical uncertainty was reﬂected in
values of the 95% highest posterior density (HPD). Finally, a
Maximum Clade Credibility (MCC) tree was summarized in
TreeAnnotator using the posterior distribution of trees and exclud-
ing a 10% burn-in.
To reveal general aspects of phylogeography, EBHSV sequences
were classiﬁed to either their country of origin (France, Germany,
Italy) or their county (n¼13) of origin within Sweden (Fig. 1),
producing a total of 16 different geographic states. To determine
whether there was more EBHSV clustering by place of sampling
than expected by chance alone, we utilized two phylogeny-trait
association tests (Association Index – AI, Parsimony Score – PS)
available in the BaTS package (Parker et al., 2008). In addition, the
Maximum Clade (MC) statistic was used to determine which
individual countries/counties showed the strongest spatial cluster-
ing. Phylogenetic uncertainty in the data was incorporated
through the use of the posterior distribution of trees determined
from the BEAST analysis above, with 1000 random permutations of
sampling locations undertaken to create a null distribution for
each statistic.
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Analysis of selection pressures
Selection pressures acting on EBHSV capsid sequences were
assessed as the ratio of non-synonymous (dN) to synonymous (dS)
nucleotide substitutions per site (i.e. dN/dS). A variety of methods
available in the HyPhy package were run on the Datamonkey web
interface (Delport et al., 2010; Kosakovsky Pond and Frost, 2005):
single likelihood ancestor counting (SLAC), ﬁxed effects likelihood
Fig. 1. Map of Southern Sweden. Location of the EBHSV positive sequenced samples is shown and counties are indicated.
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(FEL), random effects likelihood (REL), mixed effects model of
evolution (MEME) and the fast unbiased Bayesian approximation
(FUBAR). Only sites detected by at least two methods with
statistically signiﬁcant values were considered as being subject
to positive selection under these criteria (p-value o0.05 for SLAC,
FEL and MEME; posterior probability 40.95 for REL and FUBAR).
The BranchSite-REL method was also employed to detect selection
on individual branches of the EBHSV tree (Kosakovsky Pond et al.,
2011).
Antigenic analysis of EBHSV strains
The antigenic proﬁle of nine PCR-positive strains was deter-
mined using a panel of speciﬁc monoclonal antibodies (MAbs)
produced against Bs91/Italy/1991 strain (Barbieri, 1998). Four to
ﬁve samples from each main branch of the EBHSV phylogeny were
selected. The antigenic proﬁle of the strains was obtained using a
sandwich ELISA as previously described (Capucci et al., 1995) with
a hare anti-EBHSV immune serum adsorbed to the plate and MAbs
at a concentration of approximately 100 ng/mL. For each MAb, the
absorbance values were transformed in percentage of reactivity
using as 100% of reactivity the average OD values of all the samples
with an OD value equal to the strain used as standard (Bs91/Italy/
1991; 70.2 OD).
MAbs epitope prediction
Nucleotide sequences of the nine strains used in the antigenic
analyses, as well as that of the strain Ita92/Italy/1992, were aligned
and translated. The epitope of each MAb was inferred comparing
the variable amino acid positions between reactive and non-
reactive strains. Intermediate values of MAb reactivity were not
considered as they might result from other interfering factors.
Indeed, the results were obtained from livers of dead hares
collected in the ﬁeld and stored frozen for several years, which
might have caused a partial virus degradation. Nevertheless, most
of the older samples used were fully reactive for all the MAbs
tested, indicating an intact viral capsid. Inferred epitopes were
then mapped on the VP60 structural model (see below).
Homology modelling of EBHSV strains
Secondary structure prediction was performed with Jpred
(http://www.compbio.dundee.ac.uk/www-jpred), Prof (http://
www.aber.ac.uk/phiwww/prof/) and Psi-pred (http://bioinf.cs.
ucl.ac.uk/psipred). Structure templates were selected according
to e-value criterion using the WU-BLAST tool (http://www.ebi.ac.
uk/Tools/sss/wublast/). X-ray crystallographic structures with a
resolution less than 2.1 Å were arbitrarily retained. Sequence
alignment of selected templates and the sequence of the capsid
protein of EBHSV strain O282/Sweden/1984 was ﬁrst calculated
from a pairwise structure alignment automatically generated by
the Align123 algorithm implemented under Discovery Studio 4.0
(DS4.0, Accelrys, San Diego), and then manually optimized (see
Supplementary Fig. 1).
Homology modelling was performed with the Modeler pro-
gram under DS4.0 using X-ray crystallographic structures of
domain S and P of the major capsid protein from RHDV (PDB
codes: 4EJR and 4EGT, respectively). The generated models were
checked using Verify3D (http://nihserver.mbi.ucla.edu/Verify3D),
ProsaII (http://prosa.services.came.sbg.ac.at/prosa.php) and Pro-
check (http://www.ebi.ac.uk/thornton-srv/databases/pdbsum/Gen
erate.html) programs, and the structures with the best stereo-
chemical and folding qualities were retained. A series of energy
minimizations was carried out with CHARMm force ﬁeld imple-
mented under DS4.0 in a three-step procedure to relax progres-
sively the structures (1: all heavy atoms ﬁxed; 2: heavy atoms of
the backbone ﬁxed; 3: heavy atoms of the secondary structure
backbone ﬁxed) using 200 steepest descent steps with conver-
gence obtained at 0.1 rmsg, followed by conjugate gradient steps
with convergence obtained at 0.001 rmsg. The reﬁned structures
of both the S and P domains were then superimposed into the
atomic model of RHDV (PDB code 3J1P) to correctly position the
two domains relative to each other. Capsid monomers are divided
into a buried shell (S) domain connected to the protruding
(P) domain that is exposed on the surface; the P domain is
subdivided into P1 (stem of arc) and P2 (top of arc) (reviewed in
Abrantes et al. (2012)). The other strain models were then
obtained from the minimized model structure of O282/Sweden/
1984 using the “Build Mutant” tool of DS4.0 with secondary
structure restraints and a distance cut-off of 5 Å centred on the
mutated residues for including neighbouring residues in optimiza-
tion (Supplementary Fig. 2).
Results
Seventy-ﬁve Swedish samples were positive for EBHSV by PCR
(72% of the original data set) and, of those, 54 were successfully
sequenced for the complete capsid VP60 gene. The ﬁnal data set
included EBHSV strains from 52 Lepus europaeus and from two
Lepus timidus specimens. Additionally, 16 French samples were
also ampliﬁed and sequenced for the complete VP60 gene.
Both the maximum likelihood (ML) and Bayesian (MCC) trees
revealed the presence of two main phylogenetically distinct
groups (Group A and Group B), with no evidence for recombina-
tion. The MCC tree (GTRþΓþ I substitution model, constant
population size coalescent prior) is shown in Fig. 2, while the
ML tree is available from the authors on request. Group A
comprises Swedish strains from 1982 to 1989, thus representing
the early evolutionary history of EBHSV. In contrast, Group B
contains two Swedish strains from 1988, all those from the 1990s
and 2000s, as well as strains sampled from other European
countries (France, Germany and Italy). The strong time-
dependence (i.e. clock-like evolution) in the data, such that older
strains occupy a more basal phylogenetic position than those
sampled more recently, was conﬁrmed in a regression of root-to-
tip genetic distances against year of sampling inferred from the ML
tree (correlation coefﬁcient¼0.96).
Our Bayesian MCMC analysis revealed that the mean rate of
evolutionary change in EBHSV was approximately 3103
nucleotide substitutions per site per year (subs/site/year), with
little variation across coalescent models (range of 95% HPD values
of 2.6–3.6103 subs/site/year across all models). Under this
evolutionary rate, the tMRCA for EBHSV was estimated to be
between 28 and 39 years (range of 95% HPD values), which
accords to the years 1969–1980. Additionally, our phylogeographic
analysis revealed a signiﬁcant clustering of sequences by country/
province of origin under both the AI and PS phylogeny-trait
Table 1
Sequence and nucleotide positions of the PCR and sequencing primers.
Primer Primer sequence (50–30) Position (relative to
GenBank accession
number Z69620)
EBHSV_VP60_0001F ATGGAGGGTAAGCCWCGGGCTGA 5283–5305
EBHSV_VP60_0813F CAGRCACTGGAAYATGAATGG 6095–6115
EBHSV_VP60_0885R CTTGGATGRTCAATGTCGTC 6147–6166
EBHSV_VP60_1728R GACATAGGAATATCCAGTGGTGGC 6987–7010
EBHSV-29F CGGACGATAGTTTTGTGAATGT 5260–5281
EBHSV-1795R TAGAAGCTCCAGCCAATGTT 7026–7045
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association statistics (po0.01), such that there is restricted viral
trafﬁc across this spatial region. Similarly, the MC statistic revealed
signiﬁcant clustering in France and in six of the 13 Swedish
counties (Blekinge, Gotland, Örebro, Östergotland, Uppsala and
Västra Götaland) that also had the largest sample sizes.
The nine EBHSV samples selected for the antigenic study
presented ﬁve distinct antigenic proﬁles on the basis of differences
in reactivity of four MAbs (O282/Sweden/1984; O1000/Sweden/
1984EV1223/Sweden/1987EV1519/Sweden/1988EV24/Sweden/
1998EIta92/Italy/1992EBs91/Italy/1991; V1571/Sweden/1988; V58/
Sweden/1994; V708/Sweden/2008EV2070/Sweden/2008; Table 2).
The loss of reactivity in MAbs 4E3, 1H1 and 6F9 in some samples
from Group B results from epitope modiﬁcation, probably due to
the substitution of one or more amino acids responsible for
epitope conformation.
Strains in Group A (1984–1988) exhibited relatively conserved
antigenic proﬁles, being fully reactive for all MAbs but 3D6
(Table 2; Fig. 2). In contrast, strains from Group B, collected in a
range time of 20 years (1988–2008), showed a progressive varia-
tion in antigenic proﬁle. Indeed, the two strains from 2008
presented the most distinct antigenic proﬁle comparing to the
original, likely as a consequence of ﬁxation of mutations that
caused the loss of reactivity in MAbs 1H1, 6F9 and, ﬁnally, 4E3.
Since EBHSV does not grow in vitro, the classical approach of
producing escape mutants to map the epitopes is not possible.
However, comparison of the antigenic proﬁles and the genetic
1975.0 1980.0 1985.0 1990.0 1995.0 2000.0 2005.0 2010.0
O3023/Sweden/198 4
s0516 G3/France/2005
V1392/Sweden /1988
O2159/Sweden/198 4
V2070/Sweden/200 8
V1869/Sweden/198 7
E01-01/France/2001
i0305  G2-3/France/2003
V708/Sweden/200 8
s0603 G2-3/France/2006
V1394/Sweden/198 8
O4022/Sweden/198 2
O1000/Sweden/198 4
V58/Sweden/199 4
O591/Sweden/198 3
V1974/Sweden/198 7
V24/Sweden /1998
V954/Sweden/198 9
O3303/Sweden/198 3
O575/Sweden/198 3
V392/Sweden /1988
Ita92/Italy/1992
BS89/Italy/1989
V1466/Sweden /1988
O4021/Sweden/198 2
V117/Sweden /1998
i0102  G2-2/France/2001
V961/Sweden/199 4
V1069/Sweden /2008
V1970/Sweden/198 7
E0251/France/2002
V1645/Sweden /1987
V912/Sweden /1993
V78/Sweden /1985
V1900/Sweden/198 7
V715/Sweden /2002
V1278/Sweden /1988
V1223/Sweden /1987
E0330/France/2003
V1437/Sweden /1988
V1070/Sweden /2008
O3024/Sweden/198 4
V1846/Sweden /1987
V1220/Sweden /1988
V171/Sweden /2001
E0540/France/2005
O282/Sweden/198 4
V871/Sweden /1993
O3305/Sweden/198 3
V212/Sweden /1996
O1183/Sweden/198 4
s0636 G3/France/2006
V1519/Sweden/198 8
V1166/Sweden /1993
E04-53/France/2004
V707/Sweden/200 8
E0822/France/2008
V1862/Sweden /1987
E03-23/France/2003
Z69620/ France/1989
V1449/Sweden /2003
O484/Sweden/198 2
E04-35/France/2004
V1836/Sweden/198 7
i0252 /G1-1/France/2002
V1571/Sweden /1988
V25/Sweden /1985
E0836/France/2008
V1703/Sweden /2008
E02-56/France/2002
O2485/Sweden/198 4
O297/Sweden/198 3
U09199/ Germany/1989
O3891/Sweden/198 2
Year
Group A
Group B
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
1.0
Fig. 2. MCC tree estimated for the 54 Swedish and assorted European EBHSV samples. The country and year of collection are shown for each sample, while reference
sequences retrieved from GenBank have their accession number indicated. Posterior probabilities 40.9 are shown for selected nodes. Tip times reﬂect the time (year) of
sampling, while node bars depict the 95% HPD values on node times.
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differences between the strains allowed us to identify the location
of some MAbs epitopes. For MAbs 1C5, 4A4, 3H6 and 5F5 no
variation in reactivity was observed among strains, such that we
could not predict the epitopes recognized. For MAbs 2B2, 1G8, 4E3
and 6F9, several amino acid substitutions could be responsible for
the antigenic variation, but none could be conﬁdently associated
with epitope location.
Prediction of epitopes was possible for MAbs 3D6, 1F8 and 1H1
(Fig. 3), and further supported by their location in exposed regions of
the P2 subdomain of the capsid (Fig. 4A). A complete loss of binding
of MAb 1H1 is associated with the S383N mutation, as all ﬁve 1H1
positive strains have a serine at position 383, whereas 1H1 negative
strains have an asparagine. This is likely due to the bulky size of the
asparagine extending outward compared to that of serine. In addi-
tion, the L378T mutation might interfere with 1H1 reactivity, since
strain O282/Sweden/1984 presents a lower reactivity for this MAb.
According to this and our capsid structural model, for MAb 1H1 we
could demonstrate the associated conformational epitope (Fig. 4B).
However, this should be treated with caution as the L378T mutation
is not associated with a complete loss of reactivity. MAb 1F8 was not
fully reactive for strains V58/Sweden/1994 and V24/Sweden/1998.
Although no unique substitutions occur in these strains compared to
the other strains tested, the mutations at two adjacent positions
(T302A and S304G) could independently cause loss of the epitope.
With respect to 3D6, the total loss of the epitope in the strain O282/
Sweden/1984 might be related with the S408N mutation, since the
serine is present only in this strain.
Our analysis of site-speciﬁc selection pressures acting on VP60
revealed codons 383, 410 and 476 to be under putative positive
selection; codons 383 and 410 had a posterior probability 40.95
for positive selection under the REL and FUBAR models; codon 476
had a posterior probability of 1 for REL, a p-value of 0.001 for FEL,
and a posterior probability 40.95 for FUBAR. No episodic diversi-
fying selection was observed on any individual branch. Assuming
the organization of Caliciviridae genomes proposed by Neill (Neill,
1992), codons 383 and 410 are located in region E of the capsid
while codon 476 is located in the region F. For codon 383 two
different amino acids – S or N – are observed, but the physio-
chemical properties are maintained. For codon 410 ﬁve different
amino acids are found (A, T, S, P and N); interestingly, this codon
can be part of a putative N-glycosylation motif. For codon 476
eight different amino acids found in the sequences studied (A, E, T,
S, D, V, G and N); although the physiochemical properties might
change with these mutations, the phenotypic effect is uncertain.
According to our model of the capsid structure, the positively
selected codons are located at exposed regions of the capsid P
domain (Fig. 4C).
Discussion
Despite an increasing interest in calicivirus evolution (e.g. Alda
et al., 2010; Coyne et al., 2012; Mahar et al., 2013), few studies have
considered EBHSV even though it is an important agent of disease
Table 2
Antigenic results for the 11 monoclonal antibodies tested. Ita92/Italy/1992 and Bs91/Italy/1991: EBHSV positive controls. Black squares: full reactive; dark grey squares:
medium reactive; light grey squares: low reactive; white squares: not reactive. Location of each strain within the major groups of the phylogenetic tree is indicated.
Sample 1C5 4A4 3H6 5F5 2B2 3D6 1F8 1G8 4E3 1H1 6F9 Group
O282/Sweden/1984 ■ ■ ■ ■ ■ □ ■ ■ ■ A
O1000/Sweden/1984 ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ A
V1223/Sweden/1987 ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ A
V1519/Sweden/1988 ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ A
V1571/Sweden/1988 ■ ■ ■ ■ ■ ■ ■ ■ ■ □ B
V58/Sweden/1994 ■ ■ ■ ■ ■ ■ ■ □ □ B
V24/Sweden/1998 ■ ■ ■ ■ ■ ■ ■ ■ ■ B
V708/Sweden/2008 ■ ■ ■ ■ ■ ■ ■ □ □ □ B
V2070/Sweden/2008 ■ ■ ■ ■ ■ ■ ■ □ □ □ B
Ita92/Italy/1992 ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ B
Bs91/Italy/1991 ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ ■ –
Fig. 3. Amino acid alignment of the P domain of the nine strains used for the antigenic analyses. Numbers on the top of the ﬁgure correspond to the variable amino acid
positions found between strains; (.) means identity with the reference sequence. Location of the predicted MAbs epitopes is indicated at the top. Positions under putative
positive selection are shown by stars. Amino acids are coloured based on their properties: light blue for hydrophobic amino acids (I, L, A, V, F, Y, M, W); dark blue for amino
acids polar uncharged (N, T, Q, S); dark green for amino acids positive charged (R, H, K); light green for amino acids negative charged (D, E) and orange for amino acids with
special characteristics (G, P, C). Regions are according to Wang et al. (2013) and Neill (1992).
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in Europe. The ﬁrst recognized and diagnosed EBHSV outbreak
occurred in the early 1980s in Sweden (Gavier-Widén and Mörner,
1991). However, there are indications of the presence of the virus
within hare populations since at least 1976 (Bascuñana et al., 1997;
Duff et al., 1994; Duff et al., 1997).
Our phylogenetic analysis revealed striking evolutionary pat-
terns in EBHSV. A single viral lineage was apparently dominant at
the time of EBHSV emergence (Group A; Fig. 2). This lineage
spread throughout Sweden, evolving in separated genetic sub-
groups that clustered in distinct geographical areas. Group A
persisted until 1989 when it was seemingly replaced within a
few years by a new lineage (Group B) that emerged in the mid-
1980s. While Group A included only Swedish samples from 1982
to 1989, Group B included Swedish samples from the late 1980s
and all the Swedish samples from the 1990s and 2000s, along with
the other European samples (Italy, France and Germany). Thus, this
lineage contains strains detected in several European countries,
suggesting that an increased ﬁtness may have enabled it to diffuse
over a wider geographic area, at the same time out-competing the
pre-existing Group A viruses. This evolutionary pattern resembles
that observed for the antigenic variant of RHDV (RHDVa) in several
countries associated with domestic rabbit production, where it
replaced earlier RHDV strains (Lavazza and Capucci, 2008;
McIntosh et al., 2007).
Antigenic variation in EBHSV is observed from as early as 1984,
with strains presenting distinct antigenic proﬁles circulating in the
same year. This variation is also observed in 1988, coincident with
co-circulation of Groups A and B strains (V1519/Sweden/1988 and
V1571/Sweden/1988; Fig. 3). In contrast, similar antigenic proﬁles
exist in both groups, but while the phylogenetic analysis is based
on the entire capsid sequence, the antigenic analysis only shows
differences at speciﬁc locations (i.e., within epitopes). The lack of
reactivity for the MAbs 4E3, 1H1 and 6F9 that characterizes the
antigenic proﬁles of the most recent Group B strains, makes it
possible that the successful persistence of lineage B and the
replacement of lineage A is due to a change in antigenicity among
these lineages (Fig. 3). Indeed, a relationship between antigenic
variation and emergence of new outbreaks is well-established for
other caliciviruses, such as GII.4 norovirus (Allen et al., 2008;
Cannon et al., 2009; Eden et al., 2014; Lindesmith et al., 2011;
Lindesmith et al., 2008).
According to our prediction of the EBHSV secondary structure
and considering the similarities with the RHDV atomic model
(Wang et al., 2013), the positively selected codons 383, 410 and
476 are located in exposed loops of P2 and P1 subdomains of VP60,
suggesting that, as for RHDV (Esteves et al., 2008), they are
associated with host immune pressure. Codon 410 is also located
within a putative N-glycosylation motif; a similar observation was
Fig. 4. Molecular model of the P subdomain of EBHSV capsid protein VP60. (A) Positions of the putative epitopes identiﬁed for MAbs 1F8 (red), 1H1 (green) and 3D6 (blue).
(B) Details of the conformational epitope deﬁned by MAb 1H1 involving positively selected site 383. The two amino acids that modulate MAb binding are highlighted in
orange for the recognized O1000/Sweden/1984 strain and in green for the non-recognized V58/Sweden/1994 strain. (C) Location on exposed loops of the P domain of
putative positively selected sites (codons 383, 410 and 476). The S domain positioned below the P1 subdomain is not shown, since it did not harbour positively selected sites
or mutations affecting MAbs binding.
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made for RHDV and an association with virulence was hypothe-
sized (Esteves et al., 2008). Interestingly, position 383 appears to
dictate reactivity of MAb 1H1, strongly suggesting that it corre-
sponds to a major epitope under immune pressure. Our prediction
is supported by a previous study on Italian strains (Barbieri, 1998).
For MAb 1F8, the amino acids at positions 302 and 304 correspond
to the epitope recognized by this MAb. Both T4A and S4G
correspond to a loss of the OH group that seems to be associated
with the lack of reactivity. Barbieri (1998) observed a T4S change
at position 302, but the reactivity is not affected since the OH
group is maintained. The epitope recognized by MAb 1F8, but also
by MAb 3D6, is located in the P2 subdomain, which is the most
exposed region of the calicivirus capsid and a highly variable
region, being involved in the interaction with host antibodies and
histo-blood group antigens (Choi et al., 2008; Wang et al., 2013). It
is likely that the changes on the EBHSV capsid inﬂuence receptor
binding and potential host resistance as described in RHDV
(Nyström et al., 2011).
The mean rate of nucleotide substitution for EBHSV estimated
in this study, which ranges from 2.6 to 3.6103 subs/site/year, is
relatively high for an RNA virus (Duffy et al., 2008; Jenkins et al.,
2002), although similar to that recently observed for RHDV in
Australia where the virus was introduced as a novel biocontrol
agent in 1995 (Kovaliski et al., 2014). Under this rate the estimated
tMRCA for EBHSV is between 1969 and 1980 (95% HPD values)
which is concordant with its circulation a few years before the
original diagnosis in 1980. This time-scale is further supported by
(i) the reports of hares that died with lesions consistent with EBHS
in England in 1976, (ii) the identiﬁcation of EBHSV in samples
collected in the 1970s, and (iii) the detection of anti-EBHSV
antibodies in sera of hares collected previously (Bascuñana et al.,
1997; Duff et al., 1994; Duff et al., 1997). Finally, the phylogeo-
graphic results reveal a signiﬁcant clustering by country and
Swedish county of origin, such that there are constraints to viral
trafﬁc both within Sweden and more broadly across Europe. This
sites in contrast to the lack of geographical structure and rapid
spatial spread of the related RHDV in some European countries
such as Portugal, Spain and France (Alda et al., 2010; Le Gall-Reculé
et al., 2003; Le Gall et al., 1998; Müller et al., 2009).
In sum, our results show clear replacement of Group A by
Group B strains that is likely to be selectively mediated and which
may at least in part be associated with antigenic variation. The
position of Italian, German and French strains within this Group
highlights the successful dispersal and persistence of this lineage
throughout Europe. Preliminary data indicate that this lineage is
still dominant in Europe and hence merits continued monitoring.
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